Western pharmaceutical companies and investors are driving a record number of licensing deals with Chinese drugmakers that have insufficient capital to fund late-stage drug development and global expansion.
西方制药公司和投资者推动缺乏资金进行后期阶段药物开发和manbetx app苹果 扩张的manbetx3.0 药商与他们签署了创纪录数量的许可协议。
您已阅读4%（259字），剩余96%（5806字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。